ChemSpider 24643855 Formula C21H24N2 3D model (Jmol) Interactive image | ChEMBL CHEMBL592752 Molar mass 304.44 g·mol | |
 | ||
AVN-101, a close structural analogue of latrepirdine, is a selective 5-HT6 receptor antagonist which is under development by Avineuro Pharmaceuticals for the treatment of Alzheimer's disease and anxiety disorders. As of November 2013, it is in phase II clinical trials for these indications.
References
AVN-101 Wikipedia(Text) CC BY-SA